Metastatic Breast Cancer Study Receives up to $28 Million | UNC-Chapel Hill

Metastatic breast cancer study receives up to $28 million | UNC-Chapel Hill

UNC Lineberger Comprehensive Cancer Center has been awarded up to $28 million by the Advanced Research Projects Agency for Health to lead the development of a next-generation clinical trial for breast cancer that has spread to other parts of the body. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy. The Evolutionary Clinical Trial for No…

UNC's Lineberger Cancer Center Awarded $28 Million for New Clinical Trial

The UNC Lineberger Comprehensive Cancer Center has been awarded $28 million by the Advanced Research Projects Agency for Health (ARPA-H). The money will be used to develop a new clinical trial for breast cancer which has spread to other part of the body. The trial, “Translational Breast Cancer Research Consortium Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies,” which researchers have shortened to “EVOLVE,” will adapt treatment …